| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.746 | 0.006 | 0.746 | Toll-Like receptor 7 agonist | |||
| 0.739 | 0.007 | 0.739 | Toll-Like receptor agonist | |||
| 0.523 | 0.004 | 0.523 | Glutamate receptor antagonist | 0.399 0.005 DBMET03065 | ||
| 0.418 | 0.004 | 0.418 | Glutamate (mGluR) antagonist | 0.176 0.013 DBMET03065 | ||
| 0.408 | 0.003 | 0.458 | Nav1.8 sodium channel blocker | 0.458 0.003 DBMET03065 | DBMET03065 | |
| 0.39 | 0.009 | 0.516 | Protein kinase (CK1) inhibitor | 0.516 0.004 DBMET03065 | DBMET03065 | |
| 0.375 | 0.004 | 0.453 | Glutamate (mGluR) agonist | 0.453 0.004 DBMET03065 | DBMET03065 | |
| 0.335 | 0.004 | 0.359 | MAP kinase kinase 3 inhibitor | 0.359 0.004 DBMET03065 | DBMET03065 | |
| 0.322 | 0.008 | 0.399 | GABA C receptor agonist | 0.399 0.005 DBMET03065 | DBMET03065 | |
| 0.314 | 0.003 | 0.314 | GHS receptor antagonist | |||
| 0.275 | 0.003 | 0.275 | Neuraminidase (influenza) inhibitor | 0.074 0.03 DBMET03065 | ||
| 0.354 | 0.084 | 0.398 | GABA C receptor rho-3 antagonist | 0.398 0.062 DBMET03065 | DBMET03065 | |
| 0.229 | 0.006 | 0.229 | Glutamate (mGluR group I) antagonist | |||
| 0.198 | 0.004 | 0.198 | Neuraminidase inhibitor | |||
| 0.178 | 0.013 | 0.193 | Glutamate receptor agonist | 0.193 0.011 DBMET03065 | DBMET03065 | |
| 0.197 | 0.034 | 0.249 | M17 leucyl aminopeptidase inhibitor | 0.249 0.021 DBMET03065 | DBMET03065 | |
| 0.296 | 0.139 | 0.338 | MAP kinase kinase 6 inhibitor | 0.338 0.102 DBMET03065 | DBMET03065 | |
| 0.176 | 0.019 | 0.213 | GABA C receptor antagonist | 0.213 0.01 DBMET03065 | DBMET03065 | |
| 0.192 | 0.036 | 0.222 | Hemostatic | 0.222 0.026 DBMET03065 | DBMET03065 | |
| 0.206 | 0.058 | 0.269 | Peroxidase inhibitor | 0.269 0.043 DBMET03065 | DBMET03065 | |
| 0.154 | 0.009 | 0.154 | Janus tyrosine kinase 1 inhibitor | 0.143 0.011 DBMET03065 | ||
| 0.163 | 0.021 | 0.17 | DNA repair enzyme inhibitor | 0.17 0.018 DBMET03065 | DBMET03065 | |
| 0.212 | 0.07 | 0.229 | Nitric-oxide synthase stimulant | 0.229 0.05 DBMET03065 | DBMET03065 | |
| 0.147 | 0.005 | 0.147 | Glutamate (mGluR5) antagonist | |||
| 0.154 | 0.014 | 0.259 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.259 0.005 DBMET03065 | DBMET03065 | |
| 0.272 | 0.138 | 0.272 | Antiobesity | |||
| 0.138 | 0.009 | 0.138 | Bruton tyrosine kinase inhibitor | |||
| 0.133 | 0.005 | 0.176 | Glutamate (mGluR group II) agonist | 0.176 0.004 DBMET03065 | DBMET03065 | |
| 0.13 | 0.005 | 0.201 | AMPA 2 receptor antagonist | 0.201 0.004 DBMET03065 | DBMET03065 | |
| 0.316 | 0.191 | 0.353 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.353 0.147 DBMET03065 | DBMET03065 | |
| 0.123 | 0.005 | 0.164 | Glutamate (mGluR2) agonist | 0.164 0.004 DBMET03065 | DBMET03065 | |
| 0.159 | 0.049 | 0.217 | Sodium channel (voltage-gated) blocker | 0.217 0.024 DBMET03065 | DBMET03065 | |
| 0.221 | 0.115 | 0.25 | 5 Hydroxytryptamine uptake stimulant | 0.25 0.081 DBMET03065 | DBMET03065 | |
| 0.159 | 0.057 | 0.161 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.161 0.054 DBMET03065 | DBMET03065 | |
| 0.174 | 0.075 | 0.244 | Succinate dehydrogenase inhibitor | 0.244 0.024 DBMET03065 | DBMET03065 | |
| 0.198 | 0.102 | 0.235 | RNA-directed DNA polymerase inhibitor | 0.235 0.06 DBMET03065 | DBMET03065 | |
| 0.112 | 0.016 | 0.148 | MAP3K7 inhibitor | 0.148 0.01 DBMET03065 | DBMET03065 | |
| 0.127 | 0.034 | 0.147 | GABA C receptor rho-1 antagonist | 0.147 0.023 DBMET03065 | DBMET03065 | |
| 0.148 | 0.056 | 0.238 | Alpha-N-acetylglucosaminidase inhibitor | 0.238 0.025 DBMET03065 | DBMET03065 | |
| 0.121 | 0.034 | 0.147 | MAP kinase kinase 1 inhibitor | 0.147 0.018 DBMET03065 | DBMET03065 | |
| 0.086 | 0.006 | 0.086 | RNA-directed RNA polymerase inhibitor | 0.053 0.012 DBMET03065 | ||
| 0.127 | 0.049 | 0.23 | Ferrochelatase inhibitor | 0.23 0.016 DBMET03065 | DBMET03065 | |
| 0.098 | 0.019 | 0.098 | Secretase beta inhibitor | |||
| 0.121 | 0.044 | 0.148 | DOPA decarboxylase inhibitor | 0.148 0.022 DBMET03065 | DBMET03065 | |
| 0.105 | 0.028 | 0.143 | Glutamate dehydrogenase inhibitor | 0.143 0.017 DBMET03065 | DBMET03065 | |
| 0.198 | 0.126 | 0.231 | DNA synthesis inhibitor | 0.231 0.082 DBMET03065 | DBMET03065 | |
| 0.137 | 0.068 | 0.199 | Sodium channel blocker | 0.199 0.032 DBMET03065 | DBMET03065 | |
| 0.088 | 0.023 | 0.132 | Biliverdin reductase inhibitor | 0.132 0.012 DBMET03065 | DBMET03065 | |
| 0.213 | 0.148 | 0.213 | Immunomodulator | |||
| 0.068 | 0.004 | 0.072 | ATM kinase inhibitor | 0.072 0.004 DBMET03065 | DBMET03065 | |
| 0.087 | 0.025 | 0.096 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.096 0.016 DBMET03065 | DBMET03065 | |
| 0.083 | 0.022 | 0.083 | Glutamate (mGluR1) antagonist | |||
| 0.09 | 0.029 | 0.102 | CDC7 inhibitor | 0.102 0.023 DBMET03065 | DBMET03065 | |
| 0.077 | 0.018 | 0.099 | AMPA receptor antagonist | 0.099 0.012 DBMET03065 | DBMET03065 | |
| 0.11 | 0.053 | 0.146 | Adenylate kinase inhibitor | 0.146 0.028 DBMET03065 | DBMET03065 | |
| 0.094 | 0.039 | 0.115 | Porphobilinogen synthase inhibitor | 0.115 0.03 DBMET03065 | DBMET03065 | |
| 0.082 | 0.028 | 0.118 | Carbamoyl phosphate synthetase inhibitor | 0.118 0.016 DBMET03065 | DBMET03065 | |
| 0.112 | 0.059 | 0.128 | Interleukin 2 antagonist | 0.128 0.034 DBMET03065 | DBMET03065 | |
| 0.144 | 0.091 | 0.177 | Polo-like kinase-3 inhibitor | 0.177 0.06 DBMET03065 | DBMET03065 | |
| 0.195 | 0.144 | 0.258 | Tyrosine 3 hydroxylase inhibitor | 0.258 0.061 DBMET03065 | DBMET03065 | |
| 0.085 | 0.034 | 0.108 | Phenylalanine 4-hydroxylase inhibitor | 0.108 0.022 DBMET03065 | DBMET03065 | |
| 0.078 | 0.027 | 0.1 | Glutamate (mGluR6) antagonist | 0.1 0.01 DBMET03065 | DBMET03065 | |
| 0.084 | 0.035 | 0.084 | Tyk2 inhibitor | |||
| 0.121 | 0.073 | 0.192 | Protein kinase (CK1) delta inhibitor | 0.192 0.031 DBMET03065 | DBMET03065 | |
| 0.072 | 0.024 | 0.08 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.08 0.02 DBMET03065 | DBMET03065 | |
| 0.074 | 0.027 | 0.101 | Alcohol oxidase inhibitor | 0.101 0.018 DBMET03065 | DBMET03065 | |
| 0.052 | 0.005 | 0.066 | Protocollagen prolyl hydroxylase inhibitor | 0.066 0.005 DBMET03065 | DBMET03065 | |
| 0.112 | 0.065 | 0.165 | GABA receptor agonist | 0.165 0.029 DBMET03065 | DBMET03065 | |
| 0.101 | 0.054 | 0.12 | Lanosterol 14 alpha demethylase inhibitor | 0.12 0.031 DBMET03065 | DBMET03065 | |
| 0.141 | 0.1 | 0.141 | Protein kinase (CK1) gamma 3 inhibitor | 0.137 0.105 DBMET03065 | ||
| 0.258 | 0.217 | 0.329 | 5 Hydroxytryptamine release inhibitor | 0.329 0.134 DBMET03065 | DBMET03065 | |
| 0.065 | 0.025 | 0.091 | Dihydroorotate dehydrogenase inhibitor | 0.091 0.014 DBMET03065 | DBMET03065 | |
| 0.133 | 0.099 | 0.133 | Tyrosine kinase inhibitor | |||
| 0.044 | 0.01 | 0.103 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.103 0.005 DBMET03065 | DBMET03065 | |
| 0.054 | 0.021 | 0.072 | Glutamate (mGluR group III) agonist | 0.072 0.015 DBMET03065 | DBMET03065 | |
| 0.084 | 0.051 | 0.098 | Phosphodiesterase 11A inhibitor | 0.098 0.033 DBMET03065 | DBMET03065 | |
| 0.084 | 0.051 | 0.098 | Phosphodiesterase XI inhibitor | 0.098 0.033 DBMET03065 | DBMET03065 | |
| 0.056 | 0.03 | 0.067 | Aconitate hydratase inhibitor | 0.067 0.02 DBMET03065 | DBMET03065 | |
| 0.044 | 0.019 | 0.058 | Protein kinase (CK1) epsilon inhibitor | 0.058 0.009 DBMET03065 | DBMET03065 | |
| 0.051 | 0.029 | 0.051 | Glutamate (mGluR group I) agonist | 0.051 0.029 DBMET03065 | ||
| 0.045 | 0.023 | 0.055 | Thymidine kinase inhibitor | 0.055 0.016 DBMET03065 | DBMET03065 | |
| 0.072 | 0.05 | 0.094 | Aminopeptidase I inhibitor | 0.094 0.031 DBMET03065 | DBMET03065 | |
| 0.074 | 0.052 | 0.074 | Janus tyrosine kinase 2 inhibitor | 0.065 0.061 DBMET03065 | ||
| 0.192 | 0.17 | 0.24 | Insulysin inhibitor | 0.24 0.106 DBMET03065 | DBMET03065 | |
| 0.034 | 0.012 | 0.042 | Purinergic P2Y15 antagonist | 0.042 0.006 DBMET03065 | DBMET03065 | |
| 0.039 | 0.017 | 0.042 | Glutamate (mGluR4) agonist | 0.042 0.014 DBMET03065 | DBMET03065 | |
| 0.129 | 0.108 | 0.14 | GABA C receptor rho-2 antagonist | 0.14 0.087 DBMET03065 | DBMET03065 | |
| 0.05 | 0.03 | 0.062 | Adenosine deaminase inhibitor | 0.062 0.019 DBMET03065 | DBMET03065 | |
| 0.036 | 0.017 | 0.045 | Protein kinase (CK2) beta inhibitor | 0.045 0.009 DBMET03065 | DBMET03065 | |
| 0.131 | 0.113 | 0.143 | Ca2+-transporting ATPase inhibitor | 0.143 0.064 DBMET03065 | DBMET03065 | |
| 0.085 | 0.067 | 0.09 | Pim-3 kinase inhibitor | 0.09 0.058 DBMET03065 | DBMET03065 | |
| 0.074 | 0.057 | 0.086 | GABA B receptor agonist | 0.086 0.031 DBMET03065 | DBMET03065 | |
| 0.081 | 0.065 | 0.086 | mTOR complex 2 inhibitor | 0.086 0.054 DBMET03065 | DBMET03065 | |
| 0.08 | 0.064 | 0.104 | GABA A receptor agonist | 0.104 0.034 DBMET03065 | DBMET03065 | |
| 0.045 | 0.029 | 0.058 | AICAR transformylase inhibitor | 0.058 0.015 DBMET03065 | DBMET03065 | |
| 0.083 | 0.068 | 0.116 | NADH dehydrogenase inhibitor | 0.116 0.03 DBMET03065 | DBMET03065 | |
| 0.038 | 0.026 | 0.041 | Glutamate (mGluR group II) antagonist | 0.041 0.023 DBMET03065 | DBMET03065 | |
| 0.066 | 0.055 | 0.084 | Histidine decarboxylase inhibitor | 0.084 0.04 DBMET03065 | DBMET03065 | |
| 0.08 | 0.069 | 0.094 | D-Ala-D-Ala ligase inhibitor | 0.094 0.038 DBMET03065 | DBMET03065 | |
| 0.036 | 0.026 | 0.044 | Glutamate (mGluR3) antagonist | 0.044 0.017 DBMET03065 | DBMET03065 | |
| 0.13 | 0.119 | 0.152 | CF transmembrane conductance regulator agonist | 0.152 0.072 DBMET03065 | DBMET03065 | |
| 0.087 | 0.077 | 0.11 | UDP-glucose 4-epimerase inhibitor | 0.11 0.051 DBMET03065 | DBMET03065 | |
| 0.037 | 0.026 | 0.043 | Nicotinic receptor beta4 subunit antagonist | 0.043 0.02 DBMET03065 | DBMET03065 | |
| 0.082 | 0.072 | 0.113 | Triose-phosphate isomerase inhibitor | 0.113 0.036 DBMET03065 | DBMET03065 | |
| 0.04 | 0.031 | 0.049 | Kainate receptor agonist | 0.049 0.015 DBMET03065 | DBMET03065 | |
| 0.034 | 0.027 | 0.04 | AMPA receptor agonist | 0.04 0.018 DBMET03065 | DBMET03065 | |
| 0.062 | 0.054 | 0.095 | Phosphofructokinase-1 inhibitor | 0.095 0.034 DBMET03065 | DBMET03065 | |
| 0.068 | 0.061 | 0.068 | Protein kinase B beta inhibitor | |||
| 0.021 | 0.015 | 0.048 | Nociceptin (N/OFQ) receptor agonist | 0.048 0.006 DBMET03065 | DBMET03065 | |
| 0.074 | 0.067 | 0.089 | MAP kinase kinase 7 inhibitor | 0.089 0.027 DBMET03065 | DBMET03065 | |
| 0.025 | 0.02 | 0.029 | Thymidine phosphorylase inhibitor | 0.029 0.013 DBMET03065 | DBMET03065 | |
| 0.036 | 0.031 | 0.043 | Glutamate (mGluR8) agonist | 0.043 0.019 DBMET03065 | DBMET03065 | |
| 0.084 | 0.081 | 0.116 | Creatine kinase inhibitor | 0.116 0.044 DBMET03065 | DBMET03065 | |
| 0.048 | 0.045 | 0.081 | Acyl-CoA dehydrogenase inhibitor | 0.081 0.022 DBMET03065 | DBMET03065 | |
| 0.065 | 0.062 | 0.095 | Glutamate decarboxylase inhibitor | 0.095 0.033 DBMET03065 | DBMET03065 | |
| 0.026 | 0.024 | 0.044 | AMPA 3 receptor antagonist | 0.044 0.012 DBMET03065 | DBMET03065 | |
| 0.011 | 0.009 | 0.012 | Purine nucleoside phosphorylase inhibitor | 0.012 0.007 DBMET03065 | DBMET03065 | |
| 0.042 | 0.041 | 0.042 | CC chemokine 4 receptor antagonist | |||
| 0.059 | 0.059 | 0.082 | Nav1.7 sodium channel blocker | 0.082 0.032 DBMET03065 | DBMET03065 | |
| 0.062 | 0.062 | 0.084 | Polo-like kinase-2 inhibitor | 0.084 0.04 DBMET03065 | DBMET03065 | |
| 0.049 | 0.049 | 0.068 | Argininosuccinate synthase inhibitor | 0.068 0.031 DBMET03065 | DBMET03065 | |
| 0.026 | 0.026 | 0.028 | Glutamate (mGluR2) antagonist | 0.028 0.024 DBMET03065 | DBMET03065 | |
| 0.044 | 0.045 | 0.049 | Dopamine beta hydroxylase inhibitor | 0.049 0.032 DBMET03065 | DBMET03065 | |
| 0.034 | 0.04 | 0.047 | AMPA 4 receptor antagonist | 0.047 0.017 DBMET03065 | DBMET03065 | |
| 0.079 | 0.087 | 0.092 | Polo-like kinase-1 inhibitor | 0.092 0.057 DBMET03065 | DBMET03065 | |
| 0.02 | 0.03 | 0.027 | Glutamate (mGluR1) agonist | 0.027 0.014 DBMET03065 | DBMET03065 | |
| 0.026 | 0.037 | 0.032 | Caspase 6 inhibitor | 0.032 0.016 DBMET03065 | DBMET03065 | |
| 0.013 | 0.024 | 0.016 | Nicotinic acid receptor 1 antagonist | 0.016 0.014 DBMET03065 | DBMET03065 | |
| 0.039 | 0.052 | 0.054 | Ornithine carbamoyltransferase inhibitor | 0.054 0.036 DBMET03065 | DBMET03065 | |
| 0.158 | 0.172 | 0.184 | Peptidyltransferase inhibitor | 0.184 0.122 DBMET03065 | DBMET03065 | |
| 0.035 | 0.049 | 0.045 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.045 0.022 DBMET03065 | DBMET03065 | |
| 0.012 | 0.028 | 0.015 | Antibiotic Tetracycline-like | 0.015 0.012 DBMET03065 | DBMET03065 | |
| 0.039 | 0.055 | 0.051 | Glucose-6-phosphate isomerase inhibitor | 0.051 0.028 DBMET03065 | DBMET03065 | |
| 0.146 | 0.161 | 0.172 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.172 0.105 DBMET03065 | DBMET03065 | |
| 0.013 | 0.03 | 0.017 | Complement factor D inhibitor | 0.017 0.016 DBMET03065 | DBMET03065 | |
| 0.061 | 0.079 | 0.086 | Glycine receptor agonist | 0.086 0.032 DBMET03065 | DBMET03065 | |
| 0.113 | 0.131 | 0.122 | Cyclin-dependent kinase 8 inhibitor | 0.122 0.116 DBMET03065 | DBMET03065 | |
| 0.015 | 0.034 | 0.025 | Kainate receptor 4 antagonist | 0.025 0.017 DBMET03065 | DBMET03065 | |
| 0.023 | 0.043 | 0.034 | Fumarate hydratase inhibitor | 0.034 0.024 DBMET03065 | DBMET03065 | |
| 0.056 | 0.077 | 0.069 | Glutamate (mGluR7) antagonist | 0.069 0.044 DBMET03065 | DBMET03065 | |
| 0.015 | 0.036 | 0.027 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.027 0.02 DBMET03065 | DBMET03065 | |
| 0.032 | 0.054 | 0.051 | Antimetabolite | 0.051 0.031 DBMET03065 | DBMET03065 | |
| 0.029 | 0.053 | 0.04 | Membrane dipeptidase inhibitor | 0.04 0.026 DBMET03065 | DBMET03065 | |
| 0.03 | 0.055 | 0.054 | NMDA receptor subunit 3B antagonist | 0.054 0.022 DBMET03065 | DBMET03065 | |
| 0.073 | 0.099 | 0.089 | Granulocyte macrophage colony stimulating factor agonist | 0.089 0.052 DBMET03065 | DBMET03065 | |
| 0.012 | 0.041 | 0.028 | AMPA 1 receptor antagonist | 0.028 0.021 DBMET03065 | DBMET03065 | |
| 0.067 | 0.098 | 0.106 | Aminopeptidase B inhibitor | 0.106 0.061 DBMET03065 | DBMET03065 | |
| 0.07 | 0.103 | 0.099 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.099 0.055 DBMET03065 | DBMET03065 | |
| 0.024 | 0.059 | 0.032 | Glutamate (mGluR3) agonist | 0.032 0.022 DBMET03065 | DBMET03065 | |
| 0.067 | 0.101 | 0.108 | Check point kinase 2 inhibitor | 0.108 0.058 DBMET03065 | DBMET03065 | |
| 0.082 | 0.117 | 0.126 | M18 aspartyl aminopeptidase inhibitor | 0.126 0.066 DBMET03065 | DBMET03065 | |
| 0.083 | 0.119 | 0.121 | MAP kinase kinase inhibitor | 0.121 0.073 DBMET03065 | DBMET03065 | |
| 0.115 | 0.151 | 0.122 | CC chemokine 6 receptor antagonist | 0.122 0.107 DBMET03065 | DBMET03065 | |
| 0.131 | 0.169 | 0.174 | Neurotrophic factor enhancer | 0.174 0.105 DBMET03065 | DBMET03065 | |
| 0.143 | 0.181 | 0.161 | MAP kinase kinase 5 inhibitor | 0.161 0.112 DBMET03065 | DBMET03065 | |
| 0.076 | 0.119 | 0.091 | AMP-activated protein kinase stimulant | 0.091 0.084 DBMET03065 | DBMET03065 | |
| 0.043 | 0.088 | 0.064 | Purinergic P2X1 antagonist | 0.064 0.038 DBMET03065 | DBMET03065 | |
| 0.098 | 0.146 | 0.301 | Anticoagulant | 0.301 0.028 DBMET03065 | DBMET03065 | |
| 0.019 | 0.071 | 0.036 | NMDA receptor subunit 3A antagonist | 0.036 0.028 DBMET03065 | DBMET03065 | |
| 0.06 | 0.115 | 0.075 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.075 0.073 DBMET03065 | DBMET03065 | |
| 0.143 | 0.199 | 0.188 | Superoxide dismutase inhibitor | 0.188 0.131 DBMET03065 | DBMET03065 | |
| 0.055 | 0.116 | 0.085 | Opioid kappa receptor antagonist | 0.085 0.051 DBMET03065 | DBMET03065 | |
| 0.067 | 0.132 | 0.097 | Cystathionine beta-synthase inhibitor | 0.097 0.081 DBMET03065 | DBMET03065 | |
| 0.095 | 0.161 | 0.124 | Mannose-6-phosphate isomerase inhibitor | 0.124 0.094 DBMET03065 | DBMET03065 | |
| 0.056 | 0.133 | 0.09 | HIV-1 integrase (Overall Integration) inhibitor | 0.09 0.065 DBMET03065 | DBMET03065 | |
| 0.021 | 0.104 | 0.041 | Thymidylate synthase inhibitor | 0.041 0.04 DBMET03065 | DBMET03065 | |
| 0.032 | 0.127 | 0.06 | Sphingosine 1-phosphate receptor 4 agonist | 0.06 0.055 DBMET03065 | DBMET03065 | |
| 0.048 | 0.146 | 0.079 | Opioid antagonist | 0.079 0.071 DBMET03065 | DBMET03065 | |
| 0.06 | 0.16 | 0.116 | Adenylate cyclase inhibitor | 0.116 0.07 DBMET03065 | DBMET03065 | |
| 0.082 | 0.188 | 0.126 | Cell wall synthesis inhibitor | 0.126 0.091 DBMET03065 | DBMET03065 | |
| 0.093 | 0.203 | 0.125 | Adenylate cyclase stimulant | 0.125 0.113 DBMET03065 | DBMET03065 | |
| 0.092 | 0.209 | 0.136 | MAP kinase kinase 2 inhibitor | 0.136 0.134 DBMET03065 | DBMET03065 | |
| 0.083 | 0.2 | 0.126 | Arachidonic acid antagonist | 0.126 0.117 DBMET03065 | DBMET03065 | |
| 0.107 | 0.228 | 0.143 | Phospholipase C inhibitor | 0.143 0.122 DBMET03065 | DBMET03065 | |
| 0.015 | 0.175 | 0.065 | Phosphodiesterase 4A inhibitor | 0.065 0.027 DBMET03065 | DBMET03065 | |
| 0.074 | 0.262 | 0.174 | Interleukin agonist | 0.174 0.145 DBMET03065 | DBMET03065 | |
| 0.017 | 0.216 | 0.048 | Plasmin inhibitor | 0.048 0.033 DBMET03065 | DBMET03065 | |
| 0.006 | 0.234 | 0.054 | Trypsin I inhibitor | 0.054 0.011 DBMET03065 | DBMET03065 | |
| 0.088 | 0.377 | 0.209 | Antithrombotic | 0.209 0.167 DBMET03065 | DBMET03065 | |
| 0.008 | 0.3 | 0.077 | Urokinase inhibitor | 0.077 0.022 DBMET03065 | DBMET03065 | |
| 0.023 | 0.401 | 0.098 | Trypsin inhibitor | 0.098 0.018 DBMET03065 | DBMET03065 | |
| 0.024 | 0.47 | 0.145 | HERG channel blocker | 0.145 0.136 DBMET03065 | DBMET03065 | |
| 0.009 | 0.518 | 0.077 | Plasminogen activator inhibitor | 0.077 0.027 DBMET03065 | DBMET03065 | |
| 0.003 | 0.607 | 0.057 | Factor X inhibitor | 0.057 0.019 DBMET03065 | DBMET03065 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |